US$ 22.03
how big is the glp-1 market Drugs Size to Hit USD 132.79 Bn by 2035 Glucagon-like Peptide 1 (GLP-1) Analogues
Description
Two hours above range

Short-acting GLP1s cause more nausea

Most practitioners start tirzepatide at its lowest dose of 2.5 mg regardless of the previous semaglutide dose to minimize gastrointestinal side effects during the transition

"If you have to acquire something to get a platform, your risk is a lot higher," SVB Securities' Davis said
